Safety and effectiveness of blind percutaneous liver biopsy: Analysis of 1412 procedures

Hepatitis Monthly

Volumn 12, Issue 1, 2012, Pages 32-37

  Szymczak, Aleksandra ^a   Simon, Krzysztof ^a   Inglot, Malgorzata ^a   Gladysz, Andrzej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Biopsy complications; Chronic diseases; Clinical skills; Liver; Liver biopsy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLIND PERCUTANEOUS LIVER BIOPSY; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMATOTHORAX; HEMOPERITONEUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PERITONITIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PRESCHOOL CHILD; PROFESSIONAL COMPETENCE; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SEX DIFFERENCE; TREATMENT FAILURE; TREATMENT INDICATION;

EID: 84856763443     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.4388     Document Type: Article

References (25)

1. Huang JF, Hsieh MY, Dai CY, Hou NJ, Lee LP, Lin ZY, et al. The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies. Gut. 2007;56(5):736-7.
2. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986;2(2):165-73.
3. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology. 1990;99(5):1396-400.
4. Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int. 2008;28(5):705-12.
5. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut. 1995;36(3):437-41.
6. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology. 2009;49(3):1017-44.
7. Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: a quantitative reference standard. Hepatology. 1998;28(2):323-31.
8. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis. 2004;24(1):89-97.
9. Firpi RJ, Soldevila-Pico C, Abdelmalek MF, Morelli G, Judah J, Nelson DR. Short recovery time after percutaneous liver biopsy: should we change our current practices? Clin Gastroenterol Hepatol. 2005;3(9):926-9.
10. Caturelli E, Giacobbe A, Facciorusso D, Bisceglia M, Villani MR, Siena DA, et al. Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. Am J Gastroenterol. 1996;91(7):1318-21.
11. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32(3):477-81.
12. Farrell RJ, Smiddy PF, Pilkington RM, Tobin AA, Mooney EE, Temperley IJ, et al. Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol. 1999;30(4):580-7.
13. Janes CH, Lindor KD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med. 1993;118(2):96-8.
14. van der Poorten D, Kwok A, Lam T, Ridley L, Jones DB, Ngu MC, et al. Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital. Intern Med J. 2006;36(11):692-9.
15. Van Thiel DH, Gavaler JS, Wright H, Tzakis A. Liver biopsy. Its safety and complications as seen at a liver transplant center. Transplantation. 1993;55(5):1087-90.
16. Froehlich F, Lamy O, Fried M, Gonvers JJ. Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci. 1993;38(8):1480-4.
17. Perrault J, McGill DB, Ott BJ, Taylor WF. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology. 1978;74(1):103-6.
18. Wawrzynowicz-Syczewska M, Kruszewski T, Boron-Kaczmarska A. Complications of percutaneous liver biopsy. Rom J Gastroenterol. 2002;11(2):105-7.
19. Lapinski TW, Panasiuk A, Flisiak R, Wierzbicka I. [Liver biopsy: the mandatory test in liver diagnosis in adults]. Pol Merkur Lekarski. 2001;11(63):214-7.
20. Actis GC, Olivero A, Lagget M, Pellicano R, Smedile A, Rizzetto M. The practice of percutaneous liver biopsy in a gastrohepatology day hospital: a retrospective study on 835 biopsies. Dig Dis Sci. 2007;52(10):2576-9.
21. Akay S, Karasu Z, Noyan A, Pala S, Musoglu A, Ilter T, et al. Liver biopsy: is the pain for real or is it only the fear of it? Dig Dis Sci. 2007;52(2):579-81.
22. Castera L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology. 1999;30(6):1529-30.
23. Sherman KE, Goodman ZD, Sullivan ST, Faris-Young S. Liver biopsy in cirrhotic patients. Am J Gastroenterol. 2007;102(4):789-93.
24. Montalto G, Soresi M, Carroccio A, Bascone F, Tripi S, Aragona F, et al. Percutaneous liver biopsy: a safe outpatient procedure? Digestion. 2001;63(1):55-60.
25. Dixon AK, Nunez DJ, Bradley JR, Seymour CA. Failure of percutaneous liver biopsy: anatomical variation. Lancet. 1987;2(8556):437-9.